Key Companies

Key Companies

A collage of x-rays of a person 's bones and joints.
By Dr. Ahmed Donia August 12, 2024
Notable Labs is revolutionizing cancer treatment with its Predictive Precision Medicine Platform (PPMP), which simulates therapies and predicts patient responses with 95% accuracy. This groundbreaking technology leverages artificial intelligence and machine learning to generate extensive datasets from patient samples, enabling tailored treatments for each patient. In pediatric leukemia, precision diagnostics like next-generation sequencing enhance risk stratification, targeted therapies, and personalized treatment plans, potentially improving survival rates and quality of life. Notable's PPMP has shown success in predicting drug responses, such as achieving 100% accuracy in predicting clinical responses to venetoclax with decitabine in Acute Myeloid Leukemia. Rather than commercializing PPMP as a standalone product, Notable focuses on using its capabilities to enhance drug development, fast-track clinical trials, reduce risks, and improve patient outcomes by targeting responsive populations.
A yellow stethoscope is sitting on a white surface.
By Conor Prendergast August 12, 2024
Notable Labs is a biotech startup revolutionizing cancer treatment through its innovative Precision Predictive Medicine Platform (PMPP), leveraging data and technology to identify the most effective therapies for each patient. Founded by Matthew De Silva after his father's glioblastoma diagnosis, Notable Labs combines De Silva's finance background with the medical expertise of CEO Dr. Thomas Bock. The team includes esteemed professionals like Dr. Joseph Wagner, Dr. Glenn Michelson, and Scott McPherson, who collectively bring decades of experience in biotech, clinical trials, and financial strategy. Notable Labs partners with renowned hospitals and employs cutting-edge drug screening technology to provide personalized, data-driven treatment plans, significantly improving patient outcomes. With a dedicated and diverse team, Notable Labs stands at the forefront of precision oncology, offering hope and new possibilities for cancer patients worldwide.
A woman is holding a little girl in her arms.
By Dr. David Letsa August 12, 2024
Leukemia, a broad term for cancers of the blood cells, affects both the blood and bone marrow. It is most prevalent in adults over 55, but it is also the most common cancer in children under 15. Leukemia accounts for about 28% of all childhood cancers, with approximately 3,500 children diagnosed annually in the United States alone. This makes childhood leukemia responsible for nearly one out of every three cancer cases in children and teens. Pediatric leukemias are predominantly acute and can progress rapidly, presenting significant treatment challenges.
A laptop computer with a lot of code on the screen.
July 29, 2024
Explore the critical issues surrounding patient data privacy in precision medicine. This blog examines recent breaches, the sensitivity of genetic and health data, and key regulations like HIPAA and GDPR. It also covers technological solutions, best practices, and future trends in data security, providing essential insights for anyone concerned with protecting patient information in the evolving landscape of personalized healthcare.
A woman with a cast on her foot is sitting in a wheelchair.
July 29, 2024
Explore how precision medicine is revolutionizing orthopedics through genetic profiling, biomarkers, and technologies like 3D printing. This blog highlights personalized treatments for conditions like osteoarthritis, leading to better outcomes and fewer side effects. Discover the latest advancements and future potential in personalized orthopedic care.
A person is holding a syringe and a bottle of vaccine.
July 29, 2024
Personalized vaccines are transforming healthcare by providing tailored protection based on individual genetic profiles. Unlike traditional vaccines, they target specific disease characteristics for more effective prevention. This blog explores the science, benefits, and future potential of personalized vaccines, including breakthroughs like personalized cancer vaccines. Discover how this cutting-edge approach is reshaping precision medicine and improving patient outcomes.
Two syringes are sitting next to each other on a white surface.
July 29, 2024
Dive into the groundbreaking fusion of precision medicine and immunotherapy, transforming cancer treatment. This blog highlights how personalized therapies, driven by genetic profiling and immune system targeting, are enhancing treatment efficacy and reducing side effects. Explore real-world success stories and the latest advancements in this cutting-edge field. Discover how this synergy is paving the way for a new era in personalized cancer care.
A woman with a bald head is wearing a white sweater and smiling.
By Kathleen Mackay July 29, 2024
Notable Labs is transforming cancer treatment with its innovative combination therapy approach. By leveraging its Predictive Precision Medicine Platform (PPMP), Notable identifies optimal drug combinations tailored to individual patients. This methodology aims to reduce the development of resistant cancer cells and allows each drug to be used at its best dosage without intolerable side effects. The platform has shown impressive predictive accuracy in clinical trials, particularly for pediatric leukemia. Notable's commitment to precision medicine offers new hope for patients with high unmet medical needs, driving better treatment outcomes and enhancing quality of life.
A close up of a doctor wearing gloves and a stethoscope.
By Ayushi Hisaria July 29, 2024
Notable Labs' cutting-edge diagnostic technology, boasting a 95% prediction accuracy per a Stanford study, is set to revolutionize pediatric leukemia treatment by identifying the most effective therapies. Their mission centers on advancing precision diagnostics to enhance therapy efficacy for young patients. Utilizing high-throughput screening and machine learning, Notable's platform offers tailored treatment plans, significantly improving outcomes for rare and aggressive forms of leukemia. This approach holds promise for personalized medicine, ensuring each child receives optimal, life-saving care.
A scientist wearing a mask and gloves is using a computer in a laboratory.
By Scott Smith July 29, 2024
Notable Labs is revolutionizing cancer treatment with its innovative approach to combination therapy, which targets multiple cancer pathways simultaneously. Their Predictive Precision Medicine Platform (PPMP) leverages advanced data analysis and machine learning to identify the most effective drug combinations for individual patients. By using high-throughput screening and bio-simulation, Notable Labs accelerates drug development, reduces costs, and improves clinical trial success rates. This approach promises significant improvements in patient outcomes, particularly for pediatric leukemia, by providing personalized, effective treatments and minimizing side effects.
A person is taking a pill out of a drawer.
By Syeda Abeer Iqbal July 29, 2024
Notable Labs is transforming pediatric leukemia treatment with its Predictive Precision Medicines Platform (PPMP), which boasts a 97% predictive precision. This platform rapidly identifies the most effective treatments for individual patients, significantly reducing the time and cost of cancer therapy. Notable Labs focuses on personalized medicine, combining high-throughput screening and machine learning to predict patient responses and tailor treatments accordingly. Their innovative approach has shown promising results in clinical validation studies, offering new hope for improving outcomes in pediatric leukemia.
A female scientist is working on a computer in a laboratory.
By Daniel Ferry July 29, 2024
Notable Labs is a clinical-stage precision oncology company developing new cancer therapies identified by its Predictive Medicine Platform (PMP), today announced progress for the Phase 2 volasertib program following receipt of “Clearance to Proceed” from the FDA and agreement on the dosing plan for its Phase 2 clinical trial. With trial start-up activities launched in the first quarter of this year, Notable intends to initiate enrollment in the Phase 2 study for PMP-enabled development of volasertib for relapsed refractory (R/R) acute myeloid leukemia (AML) in the coming months.
A person is holding a petri dish filled with pills.
July 29, 2024
Explore the transformative potential of precision medicine in treating autoimmune diseases. This blog delves into how personalized approaches, using genetic and molecular data, are revolutionizing diagnosis and management. Precision medicine offers more effective treatments with fewer side effects by tailoring therapies to individual profiles. Discover the latest breakthroughs, challenges, and opportunities in this cutting-edge field.
A person is pouring a drink into a glass on a table.
July 29, 2024
Explore how liquid biopsies are revolutionizing precision medicine. These non-invasive tests enable early disease detection and personalized treatment by analyzing genetic material from a simple blood sample. Discover the impact of this technology on healthcare, from monitoring treatment response to creating tailored therapies for better patient outcomes.
A doctor is examining a baby in a hospital bed
July 3, 2024
Explore the transformative potential and substantial financial returns of investing in genomic research through detailed case studies. This blog delves into the journeys of pioneering companies like Illumina, 23andMe, and CRISPR Therapeutics, highlighting their financial performances, milestones, and broader impacts. Discover how strategic investments in genomic innovation can revolutionize medicine, agriculture, and various other fields while offering lucrative opportunities for investors. Gain valuable insights into the factors driving success and the future outlook of this rapidly evolving sector.
A woman in a white lab coat with a stethoscope around her neck
July 3, 2024
Explore how innovative startups are transforming healthcare through precision medicine, tailoring treatments to individual patient characteristics. Leveraging advancements in genomics, AI, and data analytics, these companies are developing groundbreaking therapies and diagnostic tools, addressing critical healthcare challenges, and enhancing patient care. Discover the potential of these trailblazing startups to revolutionize personalized medicine.
Two surgeons are operating on a patient in an operating room.
July 3, 2024
Discover the top precision medicine companies to watch in 2024 as they revolutionize healthcare with personalized treatments. Our blog highlights key innovators driving advancements in genomics and biotechnology, enhancing patient outcomes and healthcare efficiency. Stay informed on the leaders shaping the future of targeted, effective medical treatments.
A close up of a microscope in a laboratory.
June 17, 2024
Precision medicine, a transformative approach to healthcare, is fundamentally changing how we diagnose, treat, and manage diseases. Unlike traditional medicine, which often adopts a one-size-fits-all strategy, precision medicine tailors treatments to individual characteristics using advanced technologies like genomics, proteomics, and bioinformatics. This personalized approach promises more effective therapies with fewer side effects, significantly improving patient outcomes.
Share by: